Lexicon Pharmaceuticals | LXRX - Action





Action Changement Date
Abbott USD 6.99B 501M 2026-03
Acadia Pharmaceuticals USD 108.67M 77.1M 2026-06
Agios Pharmaceuticals USD 35.75M 665K 2026-06
Akebia Therapeutics USD 13.02M 22K 2026-06
Alnylam Pharmaceuticals USD 97.11M 103.04M 2026-06
AstraZeneca USD 6.93B 362M 2026-06
BioMarin Pharmaceutical USD 1.78B 509.3M 2026-06
Coherus Biosciences USD 5.67M 842K 2026-06
Eli Lilly USD 16.79B 2.26B 2026-06
Halozyme Therapeutics USD 137.14M 18.33M 2026-06
Illumina USD 629M 18M 2026-06
Insmed USD 142.38M 9.48M 2026-06
J&J USD 15.14B 561M 2026-06
Lexicon Pharmaceuticals USD 276K 5K 2026-03
MacroGenics USD 9.5M 1.59M 2026-03
MannKind USD 44.42M 4.75M 2026-06
Merck USD 6.21B 272M 2026-06
Moderna USD 280M 134M 2026-06
Novartis USD 6.22B 66M 2026-06
PTC Therapeutics USD 91.35M 15.79M 2026-06
Puma Biotechnology USD 9.48M 885K 2025-09
Sarepta Therapeutics USD 904.27M 96.84M 2026-06
Thermo Fisher Scientific USD 5.5B 71M 2026-03
Ultragenyx Pharmaceutical USD 59M 4M 2026-06
United Therapeutics USD 193.8M 15.5M 2026-06
Vanda Pharmaceuticals USD 1.85M 190K 2025-12